Androgen deprivation therapy (ADT), also called androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Androgen Deprivation Therapy (ADT) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Medicine
Surgery
Other
Market Segment by Product Application
Hospital
Clinic
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Androgen Deprivation Therapy (ADT) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Androgen Deprivation Therapy (ADT) market by identifying its various subsegments.
3.Focuses on the key global Androgen Deprivation Therapy (ADT) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Androgen Deprivation Therapy (ADT) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Androgen Deprivation Therapy (ADT) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Androgen Deprivation Therapy (ADT) Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Androgen Deprivation Therapy (ADT) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Androgen Deprivation Therapy (ADT) Segment by Type
2.1.1 Medicine
2.1.2 Surgery
2.1.3 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Other
2.3 Global Androgen Deprivation Therapy (ADT) Market Comparison by Regions (2017-2027)
2.3.1 Global Androgen Deprivation Therapy (ADT) Market Size (2017-2027)
2.3.2 North America Androgen Deprivation Therapy (ADT) Status and Prospect (2017-2027)
2.3.3 Europe Androgen Deprivation Therapy (ADT) Status and Prospect (2017-2027)
2.3.4 China Androgen Deprivation Therapy (ADT) Status and Prospect (2017-2027)
2.3.5 Japan Androgen Deprivation Therapy (ADT) Status and Prospect (2017-2027)
2.3.6 Southeast Asia Androgen Deprivation Therapy (ADT) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Androgen Deprivation Therapy (ADT) Industry Impact
2.5.1 Androgen Deprivation Therapy (ADT) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Androgen Deprivation Therapy (ADT) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Androgen Deprivation Therapy (ADT) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Androgen Deprivation Therapy (ADT) Manufacturer Market Share
3.5 Top 10 Androgen Deprivation Therapy (ADT) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Androgen Deprivation Therapy (ADT) Market
3.7 Key Manufacturers Androgen Deprivation Therapy (ADT) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Androgen Deprivation Therapy (ADT) Industry Key Manufacturers
4.1 Pfizer
4.1.1 Compan Detail
4.1.2 Pfizer Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.1.3 Pfizer 159 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Pfizer News
4.2 Astellas Pharma
4.2.1 Compan Detail
4.2.2 Astellas Pharma Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Johnson & Johnson
4.3.1 Compan Detail
4.3.2 Johnson & Johnson Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Johnson & Johnson News
4.4 Novartis International
4.4.1 Compan Detail
4.4.2 Novartis International Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.4.3 Novartis International Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Novartis International News
4.5 Merck
4.5.1 Compan Detail
4.5.2 Novartis International Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.5.3 Merck Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Merck News
4.6 Veru
4.6.1 Compan Detail
4.6.2 Veru Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.6.3 Veru Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Veru News
4.7 Sanofi
4.7.1 Compan Detail
4.7.2 Sanofi Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.7.3 Sanofi Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 GlaxoSmithKline
4.8.1 Compan Detail
4.8.2 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 GlaxoSmithKline News
4.9 Bayer
4.9.1 Compan Detail
4.9.2 Bayer Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.9.3 Bayer Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Bayer News
4.10 Orion
4.10.1 Compan Detail
4.10.2 Orion Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.10.3 Orion Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Orion News
4.11 AstraZeneca
4.11.1 Compan Detail
4.11.2 AstraZeneca Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification
4.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 AstraZeneca News
5 Global Androgen Deprivation Therapy (ADT) Market Segment by Big Type
5.1 Global Androgen Deprivation Therapy (ADT) Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Big Type (2017-2022)
5.2 Medicine Sales Growth Rate and Price
5.2.1 Global Medicine Sales Growth Rate (2017-2022)
5.2.2 Global Medicine Price (2017-2022)
5.3 Surgery Sales Growth Rate and Price
5.3.1 Global Surgery Sales Growth Rate (2017-2022)
5.3.2 Global Surgery Price (2017-2022)
5.4 Other Sales Growth Rate and Price
5.4.1 Global Other Sales Growth Rate (2017-2022)
5.4.2 Global Other Price (2017-2022)
6 Global Androgen Deprivation Therapy (ADT) Market Segment by Big Application
6.1 Global Androgen Deprivation Therapy (ADT) Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Androgen Deprivation Therapy (ADT) Forecast
7.1 Global Androgen Deprivation Therapy (ADT) Revenue, Sales and Growth Rate (2022-2027)
7.2 Androgen Deprivation Therapy (ADT) Market Forecast by Regions (2022-2027)
7.2.1 North America Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
7.2.3 China Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
7.2.4 Japan Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
7.2.5 Southeast Asia Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
7.2.6 Other Regions Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
7.3 Androgen Deprivation Therapy (ADT) Market Forecast by Type (2022-2027)
7.3.1 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Type (2022-2027)
7.3.2 Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Type (2022-2027)
7.4 Androgen Deprivation Therapy (ADT) Market Forecast by Application (2022-2027)
7.4.1 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Application (2022-2027)
7.4.2 Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Androgen Deprivation Therapy (ADT) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Androgen Deprivation Therapy (ADT) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Androgen Deprivation Therapy (ADT)
Figure Market Concentration Ratio and Market Maturity Analysis of Androgen Deprivation Therapy (ADT)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Androgen Deprivation Therapy (ADT) Market Size by Big Type
Figure Global Market Share of Androgen Deprivation Therapy (ADT) by Big Type in 2021
Figure Medicine Picture (2017-2022)
Figure Surgery Picture (2017-2022)
Global Androgen Deprivation Therapy (ADT) Market Size by Big Application
Table Global Androgen Deprivation Therapy (ADT) Market Size by Application
Figure Global Androgen Deprivation Therapy (ADT) Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Androgen Deprivation Therapy (ADT) Comparison by Regions (M USD) (2017-2027)
Figure Global Androgen Deprivation Therapy (ADT) Market Size (Million US$) (2017-2027)
Figure North America Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate (2017-2027)
Figure China Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Androgen Deprivation Therapy (ADT) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Androgen Deprivation Therapy (ADT) Sales by Manufacturer (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Sales Market Share by Manufacturer in 2021
Table Global Androgen Deprivation Therapy (ADT) Revenue by Manufacturer (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Manufacturer in 2021
Table Global Androgen Deprivation Therapy (ADT) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Androgen Deprivation Therapy (ADT) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Androgen Deprivation Therapy (ADT) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Androgen Deprivation Therapy (ADT) Market
Table Key Manufacturers Androgen Deprivation Therapy (ADT) Product Type
Table Mergers & Acquisitions Planning
Table Pfizer Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Pfizer
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Astellas Pharma Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Astellas Pharma
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Astellas Pharma Recent Development
Table Johnson & Johnson Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Johnson & Johnson
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis International Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Novartis International
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis International Main Business
Table Novartis International Recent Development
Table Novartis International Main Business
Table Novartis International Recent Development
Table Merck Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Merck
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Veru Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Veru
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Veru Main Business
Table Veru Recent Development
Table Sanofi Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Sanofi
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table GlaxoSmithKline Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of GlaxoSmithKline
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Bayer Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Bayer
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Orion Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of Orion
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Orion Main Business
Table Orion Recent Development
Table AstraZeneca Company Profile
Table Androgen Deprivation Therapy (ADT) Product Introduction, Application and Specification of AstraZeneca
Table Androgen Deprivation Therapy (ADT) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Figure Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales by Regions (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Sales Market Share by Regions in 2021
Table Global Androgen Deprivation Therapy (ADT) Revenue by Regions (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Regions in 2021
Figure North America Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2017-2022)
Figure Europe Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2017-2022)
Figure China Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2017-2022)
Figure Japan Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2017-2022)
Figure Other Regions Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales by Big Type (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales Market Share by Big Type (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Sales Market Share by Big Type in 2019
Table Global Androgen Deprivation Therapy (ADT) Revenue by Big Type (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Big Type (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Big Type in 2019
Figure Global Medicine Sales Growth Rate (2017-2022)
Figure Global Medicine Price (2017-2022)
Figure Global Surgery Sales Growth Rate (2017-2022)
Figure Global Surgery Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales by Big Application (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales Market Share by Big Application (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2022-2027)
Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2022-2027)
Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Regions (2022-2027)
Table Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Regions (2022-2027)
Figure North America Sales Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
Figure Europe Sales Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
Figure China Sales Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
Figure Japan Sales Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
Figure Southeast Asia Sales Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
Figure Other Regions Sales Androgen Deprivation Therapy (ADT) Market Forecast (2022-2027)
Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Type (2022-2027)
Table Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Type (2022-2027)
Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Application (2022-2027)
Table Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgen Deprivation Therapy (ADT)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Androgen Deprivation Therapy (ADT) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Androgen Deprivation Therapy (ADT) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Androgen Deprivation Therapy (ADT) Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Androgen Deprivation Therapy (ADT) Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Androgen Deprivation Therapy (ADT) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer